JP2004518403A5 - - Google Patents

Download PDF

Info

Publication number
JP2004518403A5
JP2004518403A5 JP2001577462A JP2001577462A JP2004518403A5 JP 2004518403 A5 JP2004518403 A5 JP 2004518403A5 JP 2001577462 A JP2001577462 A JP 2001577462A JP 2001577462 A JP2001577462 A JP 2001577462A JP 2004518403 A5 JP2004518403 A5 JP 2004518403A5
Authority
JP
Japan
Prior art keywords
target
ligand
bound
library
isolated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001577462A
Other languages
English (en)
Japanese (ja)
Other versions
JP4966470B2 (ja
JP2004518403A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/011811 external-priority patent/WO2001079479A2/en
Publication of JP2004518403A publication Critical patent/JP2004518403A/ja
Publication of JP2004518403A5 publication Critical patent/JP2004518403A5/ja
Application granted granted Critical
Publication of JP4966470B2 publication Critical patent/JP4966470B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2001577462A 2000-04-14 2001-04-11 選択性標的化方法 Expired - Fee Related JP4966470B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19725900P 2000-04-14 2000-04-14
US60/197,259 2000-04-14
PCT/US2001/011811 WO2001079479A2 (en) 2000-04-14 2001-04-11 Methods for selective targeting

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011164796A Division JP5689764B2 (ja) 2000-04-14 2011-07-27 選択性標的化方法

Publications (3)

Publication Number Publication Date
JP2004518403A JP2004518403A (ja) 2004-06-24
JP2004518403A5 true JP2004518403A5 (enExample) 2012-04-05
JP4966470B2 JP4966470B2 (ja) 2012-07-04

Family

ID=22728668

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2001577462A Expired - Fee Related JP4966470B2 (ja) 2000-04-14 2001-04-11 選択性標的化方法
JP2011164796A Expired - Fee Related JP5689764B2 (ja) 2000-04-14 2011-07-27 選択性標的化方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011164796A Expired - Fee Related JP5689764B2 (ja) 2000-04-14 2011-07-27 選択性標的化方法

Country Status (12)

Country Link
US (5) US20020098524A1 (enExample)
EP (1) EP1360500B1 (enExample)
JP (2) JP4966470B2 (enExample)
AT (1) ATE455304T1 (enExample)
AU (1) AU2001257012A1 (enExample)
CA (1) CA2405715C (enExample)
CY (1) CY1109876T1 (enExample)
DE (1) DE60141088D1 (enExample)
DK (1) DK1360500T3 (enExample)
ES (1) ES2338097T3 (enExample)
PT (1) PT1360500E (enExample)
WO (1) WO2001079479A2 (enExample)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7129326B2 (en) * 2000-04-14 2006-10-31 Genencor International, Inc. Methods for selective targeting
ATE455304T1 (de) 2000-04-14 2010-01-15 Genencor Int Verfahren zur selektiven zielen
WO2002047717A2 (en) * 2000-12-14 2002-06-20 Genencor International, Inc. Targeted enzyme prodrug therapy
US20050100963A1 (en) 2002-03-01 2005-05-12 Dyax Corporation KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US20060135433A1 (en) * 2002-10-08 2006-06-22 Murray Christopher J Phenolic binding peptides
EP2581383A1 (en) 2002-11-25 2013-04-17 Genencor International, Inc. Skin or hair binding peptides
US20050226839A1 (en) * 2003-09-08 2005-10-13 Xueying Huang Pepetide-based body surface reagents for personal care
US7220405B2 (en) * 2003-09-08 2007-05-22 E. I. Du Pont De Nemours And Company Peptide-based conditioners and colorants for hair, skin, and nails
US7585495B2 (en) 2003-09-08 2009-09-08 E. I. Du Pont De Nemours And Company Method for identifying shampoo-resistant hair-binding peptides and hair benefit agents therefrom
US7285264B2 (en) * 2003-09-08 2007-10-23 E.I. Du Pont De Nemours And Company Peptide-based body surface coloring reagents
US20050054752A1 (en) * 2003-09-08 2005-03-10 O'brien John P. Peptide-based diblock and triblock dispersants and diblock polymers
US7807141B2 (en) 2003-09-08 2010-10-05 E.I. Du Pont De Nemours And Company Peptide-based oral care surface reagents for personal care
CN102138869B (zh) 2003-09-08 2013-05-01 纳幕尔杜邦公司 基于肽的用于毛发、皮肤和指甲的调理剂和着色剂
US20100311641A1 (en) * 2003-09-08 2010-12-09 E. I. Du Pont De Nemours And Company Peptide-based body surface coloring reagents
ES2375360T3 (es) * 2003-11-06 2012-02-29 Danisco Us Inc. Péptidos soportados y de unión a vegf para tratar enfermedades de la piel.
US9062392B2 (en) * 2003-12-30 2015-06-23 Intel Corporation Methods for isolating a peptide methods for identifying a peptide
US20070196305A1 (en) * 2005-03-01 2007-08-23 Hong Wang Method for identifying hair conditioner-resistant hair-binding peptides and hair benefit agents therefrom
EP1880007A2 (en) * 2005-05-05 2008-01-23 Genencor International, Inc. Personal care compositions and methods for their use
US20060286047A1 (en) * 2005-06-21 2006-12-21 Lowe David J Methods for determining the sequence of a peptide motif having affinity for a substrate
US20070065387A1 (en) * 2005-09-16 2007-03-22 Beck William A Method for enhancing the effect of particulate benefit agents
US7736633B2 (en) 2005-09-28 2010-06-15 E.I. Du Pont De Nemours And Company Method for enhancing effects of colorants and conditioners
US8318659B2 (en) 2005-11-15 2012-11-27 E I Du Pont De Nemours And Company Peptide-based organic sunscreens
US7858581B2 (en) * 2005-12-15 2010-12-28 E. I. Du Pont De Nemours And Company PMMA binding peptides and methods of use
US7700716B2 (en) 2005-12-15 2010-04-20 E. I. Du Pont De Nemours And Company Polytetrafluoroethylene binding peptides and methods of use
US7709601B2 (en) 2005-12-15 2010-05-04 E. I. Du Pont De Nemours And Company Nylon binding peptides and methods of use
US7906617B2 (en) 2005-12-15 2011-03-15 E. I. Du Pont De Nemours And Company Polyethylene binding peptides and methods of use
US7632919B2 (en) * 2005-12-15 2009-12-15 E.I. Du Pont De Nemours And Company Polystyrene binding peptides and methods of use
US7928076B2 (en) 2005-12-15 2011-04-19 E. I. Du Pont De Nemours And Company Polypropylene binding peptides and methods of use
WO2007109299A2 (en) * 2006-03-21 2007-09-27 Duke University Peptide
US7749957B2 (en) 2006-04-06 2010-07-06 E.I. Du Pont De Nemours And Company Clay-binding peptides and methods of use
DE102006030028A1 (de) * 2006-06-29 2008-02-14 Forschungszentrum Jülich GmbH Verfahren zum Auffinden von spezifisch an einen Köder bindende Moleküle, sowie spezifisch an einen Köder bindende Moleküle und deren Verwendung
US20080280810A1 (en) * 2006-10-30 2008-11-13 O'brien John P Peptides having affinity for body surfaces
US20080175798A1 (en) * 2006-12-11 2008-07-24 Beck William A Peptide-based hair protectants
US7678883B2 (en) 2007-07-25 2010-03-16 E.I. Du Pont De Nemours And Company Solubility tags for the expression and purification of bioactive peptides
US7829311B2 (en) 2007-07-25 2010-11-09 E.I. Du Pont De Nemours And Company Ketosteroid isomerase inclusion body tag engineered to be acid-resistant by replacing aspartates with glutamate
US7951559B2 (en) * 2007-07-25 2011-05-31 E.I. Du Pont De Nemours And Company Recombinant peptide production using a cross-linkable solubility tag
US7754680B2 (en) 2007-07-26 2010-07-13 E. I. Du Pont De Nemours And Company Peptides for binding calcium carbonates and methods of use
US20090142283A1 (en) * 2007-11-30 2009-06-04 E. I. Du Pont De Nemours And Company Peptide-based antidandruff reagents
US7998702B2 (en) * 2008-09-17 2011-08-16 E. I. Du Pont De Nemours And Company Mutant arabinose promoter for inducible gene expression
US7772181B2 (en) * 2008-10-15 2010-08-10 Danisco Us Inc. Personal care compositions comprising modified variant Bowman Birk Protease Inhibitors
US7803902B2 (en) * 2008-10-15 2010-09-28 Danisco Us Inc. Modified variant bowman birk protease inhibitors
JP5740308B2 (ja) 2008-10-15 2015-06-24 ダニスコ・ユーエス・インク 修飾変異ボウマンブリックプロテアーゼインヒビター
US20100158837A1 (en) 2008-12-18 2010-06-24 E. I. Du Pont De Nemours And Company Iron oxide-binding peptides
US8697654B2 (en) * 2008-12-18 2014-04-15 E I Du Pont De Nemours And Company Peptide linkers for effective multivalent peptide binding
US7915011B2 (en) * 2009-03-05 2011-03-29 E.I. Du Pont De Nemours And Company Host cell modifications that improve peptide production and downstream processing
US8481678B2 (en) 2009-03-30 2013-07-09 E I Du Pont De Nemours And Company Peptide-based tooth whitening reagents
EP2414045A2 (en) * 2009-03-30 2012-02-08 Johnson & Johnson Peptide-based systems for delivery of costmetic agents
US20100310495A1 (en) * 2009-06-08 2010-12-09 E. I. Du Pont De Nemours And Company Peptides having affinity for poly (benzyl methacrylate-co-methacrylic acid) potassium salt copolymers and methods of use
US20130224730A1 (en) * 2009-11-18 2013-08-29 Arizona Board Of Regents Acting For And On Behalf Of Arizona State University Peptide ligands
US8609621B2 (en) 2010-11-15 2013-12-17 E I Du Pont De Nemours And Company Acid-cleavable linkers exhibiting altered rates of acid hydrolysis
KR20140114269A (ko) 2010-12-20 2014-09-26 이 아이 듀폰 디 네모아 앤드 캄파니 표적화된 과가수분해효소
MX2013006994A (es) 2010-12-20 2013-07-29 Du Pont Generacion enzimatica de peracidos para usarse en productos para el cuidado oral.
US9273336B2 (en) 2011-02-21 2016-03-01 E. I. Du Pont De Nemours And Company Recombinant host cells having an increase in buoyant density
US9062312B2 (en) 2011-06-21 2015-06-23 Danisco Us Inc. Fusion peptides comprising multi-functional peptidic solubility tags for efficient production, processing and surface applications
WO2014179363A1 (en) 2013-04-29 2014-11-06 Adimab, Llc Polyspecificity reagents, methods for their preparation and use
EP3399033B1 (en) * 2015-12-28 2024-11-06 Idemitsu Kosan Co.,Ltd. Peptide tag and tagged protein including same
CN110453292B (zh) * 2019-06-28 2021-06-29 浙江大学 一种利用噬菌体抗体库高效筛选纤维蛋白原的方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2437090A1 (de) 1974-08-01 1976-02-19 Hoechst Ag Reinigungsmittel
US3929676A (en) * 1974-08-02 1975-12-30 Int Flavors & Fragrances Inc Bicyclic fragrance materials and processes therefor
US4760025A (en) * 1984-05-29 1988-07-26 Genencor, Inc. Modified enzymes and methods for making same
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4800197A (en) * 1987-07-17 1989-01-24 Richardson-Vicks Inc. Anti-acne composition
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5011681A (en) * 1989-10-11 1991-04-30 Richardson-Vicks, Inc. Facial cleansing compositions
US5283173A (en) * 1990-01-24 1994-02-01 The Research Foundation Of State University Of New York System to detect protein-protein interactions
US5061620A (en) * 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
CA2084307A1 (en) 1990-06-01 1991-12-02 Cetus Oncology Corporation Compositions and methods for identifying biologically active molecules
ATE318832T1 (de) * 1990-06-11 2006-03-15 Gilead Sciences Inc Verfahren zur vervendung von nukleinsäureliganden
US5723286A (en) 1990-06-20 1998-03-03 Affymax Technologies N.V. Peptide library and screening systems
US5292646A (en) * 1991-02-06 1994-03-08 Genetics Institute, Inc. Peptide and protein fusions to thioredoxin and thioredoxin-like molecules
US5270181A (en) * 1991-02-06 1993-12-14 Genetics Institute, Inc. Peptide and protein fusions to thioredoxin and thioredoxin-like molecules
US5665539A (en) * 1991-07-12 1997-09-09 The Regents Of The University Of California Immuno-polymerase chain reaction system for antigen detection
US5582981A (en) * 1991-08-14 1996-12-10 Gilead Sciences, Inc. Method for identifying an oligonucleotide aptamer specific for a target
US5270170A (en) * 1991-10-16 1993-12-14 Affymax Technologies N.V. Peptide library and screening method
US5733731A (en) * 1991-10-16 1998-03-31 Affymax Technologies N.V. Peptide library and screening method
US5605793A (en) * 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US5677136A (en) * 1994-11-14 1997-10-14 Systemix, Inc. Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof
US6341256B1 (en) * 1995-03-31 2002-01-22 Curagen Corporation Consensus configurational bias Monte Carlo method and system for pharmacophore structure determination
US5609826A (en) 1995-04-17 1997-03-11 Ontogen Corporation Methods and apparatus for the generation of chemical libraries
US6475806B1 (en) 1995-06-07 2002-11-05 Praecis Pharmaceuticals, Inc. Anchor libraries and identification of peptide binding sequences
ES2200084T3 (es) 1995-12-18 2004-03-01 Praecis Pharmaceuticals Incorporated Metodos para identificar compuestos que se unen a una diana.
EP0904540A1 (en) 1996-03-22 1999-03-31 Ontogen Corporation Methods for spatially-dispersed positionally-encoded combinatorial library synthesis
ATE250668T1 (de) 1997-05-28 2003-10-15 Discerna Ltd Ribosom-komplexe als selektionspartikel für die in vitro anzeige und evolution von proteinen
GB9716094D0 (en) * 1997-07-30 1997-10-01 Univ Glasgow Mehods for screening bacteriophage libraries
US6639051B2 (en) * 1997-10-20 2003-10-28 Curis, Inc. Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto
GB9805793D0 (en) * 1998-03-18 1998-05-13 Glaxo Group Ltd Sodium ion channels
US6861227B2 (en) * 1998-03-19 2005-03-01 Human Genome Sciences, Inc. Antibodies to cytokine receptor common gamma chain like
US6201104B1 (en) 1998-12-04 2001-03-13 Entremed, Inc. Angiogenesis—inhibiting protein binding peptides and proteins and methods of use
ATE455304T1 (de) 2000-04-14 2010-01-15 Genencor Int Verfahren zur selektiven zielen

Similar Documents

Publication Publication Date Title
JP2004518403A5 (enExample)
WO2003029458A3 (de) Verfahren zur herstellung von protein-bibliotheken und zur selektion von proteinen daraus
JP2005514030A5 (enExample)
AU2001257012A1 (en) Methods for selective targeting
WO2003087129A3 (en) Immunogenic peptides, and method of identifying same
WO2002085926A3 (de) Verfahren zur herstellung stabiler, regenerierbarer antikörper-arrays
WO2002102993A3 (en) Human secreted proteins
WO2001055301A8 (en) Nucleic acids, proteins, and antibodies
JP2005517025A5 (enExample)
Yamazaki et al. Orthogonal enzyme arrays on a DNA origami scaffold bearing size-tunable wells
WO2001054472A8 (en) Nucleic acids, proteins, and antibodies
WO2001055306A3 (en) Nucleic acids, proteins, and antibodies
WO2002077186A3 (en) Human secreted proteins
WO2006014498A3 (en) Universal antibody libraries
WO2002004949A3 (en) Reagents and methods for identification of binding agents
WO2000053742A3 (en) Polynucleotides and proteins encoded thereby
WO2000035484A3 (en) Methods and compositions for decreasing allergic reactions to surface allergens
WO2002026930A3 (en) Nucleic acids, proteins, and antibodies
WO2003040345A3 (en) Type 2 cytokine receptor and nucleic acids encoding same
SE9401650D0 (sv) Nytt sätt att identifiera peptider samt hjälpmedel som kan användas vid sättet
WO2002016424A3 (de) Dna-bindende peptiddomänen und ein verfahren zur bereitstellung solcher domänen
WO2003029828A3 (de) Screeningverfahren für verschiedene indikationen mit bnpi und/oder dnpi
JP2004500829A5 (enExample)
JP2003523193A5 (enExample)
WO2001040461A3 (de) cDNA-SEQUENZEN VON ZWEI INTERAKTOREN FANCIP4 UND FANCIP5 DER FANCONI-ANÄMIE-PROTEINE DER KOMPLEMENTATIONSGRUPPEN A UND C